Executive Director, Global Regulatory Strategy, Oncology

Moderna•Princeton, NJ
•$224,900 - $404,600•Hybrid

About The Position

The Executive Director, Global Regulatory Strategy, Oncology provides senior strategic leadership for global regulatory strategies supporting select early oncology and therapeutics programs. The role shapes the path for innovative medicines from early development toward pivotal studies, registration, and lifecycle management, with responsibility for scientifically rigorous, forward-looking strategies for complex modalities, including mRNA-based therapies. As a senior leader within Global Regulatory Science, this position anticipates evolving regulatory expectations, identifies opportunities to accelerate development, and informs portfolio, investment, and program decisions. The role partners with senior leaders across Research, Clinical Development, Regulatory CMC, Safety, Translational Medicine, Commercial, and other functions, and represents Moderna in high-level interactions and negotiations with global Health Authorities. It also guides, coaches, and mentors regulatory professionals and strengthens organizational regulatory capabilities. The position may use Generative AI and other emerging digital tools to improve regulatory intelligence, knowledge synthesis, scenario evaluation, and strategic decision-making. The working model is 70% in-office, with in-person collaboration emphasized. The position is based in a smoke-free, alcohol-free, and drug-free work environment. The stated salary range is $224,900 to $404,600. The successful candidate may also be eligible for an annual discretionary bonus, other incentive compensation, or an equity award, subject to plan eligibility criteria and individual performance.

Requirements

  • Bachelor's degree in a scientific, medical, pharmaceutical, or related discipline.
  • At least 15 years of progressive Regulatory Affairs experience in the pharmaceutical or biotechnology industry, including significant experience leading global regulatory strategies for oncology programs.
  • Extensive oncology drug-development experience, particularly in early clinical development, with a track record of advancing programs toward late-stage development, registration, and approval.
  • Experience serving as a Global Regulatory Lead for complex development programs, leading cross-functional regulatory strategy and contributing to major regulatory submissions and product approvals.
  • Demonstrated experience leading, mentoring, and developing regulatory professionals.
  • Deep knowledge of global oncology regulatory requirements and pathways, particularly in the United States and European Union, including expedited development and approval programs.
  • Ability to develop innovative, science-driven regulatory strategies that optimize clinical plans, accelerate timelines, and establish efficient registration pathways.
  • Extensive experience leading Health Authority interactions and negotiations, including alignment on clinical development plans, pivotal trial designs, and regulatory requirements.
  • Strong understanding of regulatory submissions, including investigational applications, CTD/eCTD formats, and major marketing applications such as BLAs, NDAs, and MAAs.
  • Ability to critically evaluate complex scientific and clinical data, regulatory precedents, and emerging regulatory trends to inform strategic decisions.
  • Ability to partner with program teams and executive leadership, challenge conventional approaches, evaluate innovative development scenarios, and influence critical program decisions.
  • Exceptional strategic thinking, judgment, and problem-solving skills, including the ability to navigate ambiguity, anticipate regulatory challenges, and balance scientific, regulatory, and business considerations.
  • Ability to lead through influence, build cross-functional alignment, and drive decisions in a complex global organization.
  • Exceptional communication and negotiation skills, including the ability to communicate regulatory strategies and recommendations to senior executives, Health Authorities, and external stakeholders.
  • Forward-looking, proactive, and collaborative leadership style, with a commitment to developing talent, fostering innovation, and advancing medicines for patients.

Nice To Haves

  • Advanced degree such as an MS, PharmD, PhD, MD, or equivalent.
  • Experience with innovative therapeutic modalities, including mRNA-based therapies, immuno-oncology, or other emerging oncology technologies.

Responsibilities

  • Serve as the senior Global Regulatory Lead for select strategically important oncology programs and define and drive integrated global regulatory strategies.
  • Establish scientifically sound, forward-looking regulatory direction aligned globally and with company development and business objectives.
  • Partner with program teams and executive leadership to develop science-driven regulatory approaches that accelerate development, optimize clinical plans, and establish pathways to registration.
  • Shape early development plans, including clinical development strategies, evidence-generation requirements, regulatory milestones, and considerations for transition to pivotal development.
  • Anticipate and navigate regulatory challenges associated with innovative therapeutic modalities, including mRNA-based therapies.
  • Monitor evolving global regulatory expectations and identify opportunities involving innovative pathways, expedited development programs, regulatory precedents, and emerging regulatory science.
  • Advise program teams and senior leaders on regulatory challenges, options, risks, opportunities, and trade-offs relevant to program and investment decisions.
  • Lead global Health Authority engagement strategies, including interactions with the FDA, EMA, and other agencies, to seek alignment on development plans, evidence requirements, and registration pathways.
  • Represent Moderna in Health Authority meetings and negotiations; articulate scientific and regulatory positions and advocate for innovative development approaches.
  • Develop regulatory positions and negotiation strategies and drive resolution of complex issues with Health Authorities.
  • Provide strategic oversight of regulatory submissions and interactions, including investigational applications, briefing packages, correspondence, and other filings.
  • Identify and lead resolution of regulatory issues that could affect development timelines, trial design, pivotal development, or registration opportunities.
  • Serve as a core program-team member, partnering across functions to create integrated development strategies that balance scientific rigor, regulatory expectations, and speed to patients.
  • Partner with executive leadership and program governance bodies to evaluate development scenarios, challenge conventional approaches, and recommend options while managing regulatory risk.
  • Represent Global Regulatory Strategy in governance and senior leadership discussions, communicating regulatory risks and opportunities and influencing development, portfolio, and investment decisions.
  • Drive alignment across global and regional regulatory functions and external partners, as applicable, to coordinate strategies, Health Authority positions, and execution of program priorities.
  • Provide strategic leadership, guidance, coaching, and mentorship to regulatory professionals, supporting organizational capabilities and a culture of high performance, accountability, scientific curiosity, and strategic thinking.
  • Develop regulatory capabilities in early development strategy, innovative pathways, and Health Authority engagement through coaching, knowledge sharing, and strategic guidance.
  • Promote regulatory excellence, regulatory intelligence, best practices, and continuous learning across oncology programs and Global Regulatory Science.
  • Monitor emerging regulatory policies, scientific developments, and industry trends relevant to oncology and innovative modalities, and translate insights into actionable strategies.
  • Contribute to the evolution of regulatory capabilities, processes, and strategic excellence across Moderna.
  • Explore and apply Generative AI and emerging digital tools, where appropriate, to enhance regulatory intelligence, synthesize information, evaluate scenarios, and improve regulatory decision-making.

Benefits

  • Competitive healthcare and voluntary benefit programs.
  • Fitness, mindfulness, and mental health support.
  • Family planning benefits, including fertility, adoption, and surrogacy support.
  • Paid time off, including vacation, volunteer days, sabbatical, global recharge days, and a discretionary year-end shutdown.
  • Savings and investment programs.
  • Location-specific perks and extras.
  • Potential eligibility for an annual discretionary bonus, other incentive compensation, or an equity award, subject to plan eligibility criteria and individual performance.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service